Scrip
Fetal exposure to Depakote needs further study, FDA panel says
25 June 2009
Nancy Faigen
Please Login to read the full article.
25 June 2009
Nancy Faigen
nancy.faigen@informausa.com
At a June 23rd meeting, the US
FDA's paediatric advisory committee unanimously concurred, by a vote of 11-0, with a report from agency safety researchers recommending further study of developmental delay reported in children whose mothers took Abbott Laboratories' anti-epileptic Depokote (divalproex...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
